Market Closed -
Other stock markets
|
Pre-market 07:50:01 pm | |||
128.7 USD | -0.49% | 130.5 | +1.43% |
May. 14 | US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine | RE |
May. 13 | Merck: phase 3 trial in melanoma halted | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.02% | 327B | |
+31.06% | 682B | |
+30.35% | 586B | |
-3.42% | 364B | |
+4.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.12% | 165B | |
-1.42% | 161B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Cantor Fitzgerald Adjusts Merck & Co.' Price Target to $155 From $135, Keeps Overweight Rating